APO Research
Talk to an analyst

APO RESEARCH · REPORT

Psilocybin Assisted Therapy

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Psilocybin Assisted Therapy Industry Growth and Trends Forecast to 2032

31 December 2025109 pages

Choose your research edition.

Industry ResearchPsilocybin Assisted Therapy Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Psilocybin Assisted Therapy Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Psilocybin Assisted Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Psilocybin Assisted Therapy Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Psilocybin Assisted Therapy Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Psilocybin Assisted Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Psilocybin Assisted Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Psilocybin Assisted Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Psilocybin Assisted Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Psilocybin Assisted Therapy include ATAI Life Sciences, Compass Pathways, DemeRx, Eleusis, Field Trip, Hikma Pharmaceuticals PLC, Jazz Pharmaceuticals, MindMed and Verrian, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Psilocybin Assisted Therapy market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Psilocybin Assisted Therapy market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Psilocybin Assisted Therapy market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Psilocybin Assisted Therapy.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Psilocybin Assisted Therapy market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Psilocybin Assisted Therapy Market by Company

ATAI Life Sciences

Compass Pathways

DemeRx

Eleusis

Field Trip

Hikma Pharmaceuticals PLC

Jazz Pharmaceuticals

MindMed

Verrian

Pfizer

Psilocybin Assisted Therapy Segment by Type

Natural

Synthetic

Psilocybin Assisted Therapy Segment by Application

Psychiatric Disorders

Anxiety Disorders

Cluster Headaches

Psilocybin Assisted Therapy Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Psilocybin Assisted Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Psilocybin Assisted Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Psilocybin Assisted Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Psilocybin Assisted Therapy manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Psilocybin Assisted Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Natural Table 2. Major Company of Synthetic Table 3. Global Psilocybin Assisted Therapy Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Psilocybin Assisted Therapy Sales by Type (2021-2026) & (K Units) Table 5. Global Psilocybin Assisted Therapy Sales Market Share in Volume by Type (2021-2026) Table 6. Global Psilocybin Assisted Therapy Sales by Type (2021-2026) & (US$ Million) Table 7. Global Psilocybin Assisted Therapy Sales Market Share in Value by Type (2021-2026) Table 8. Global Psilocybin Assisted Therapy Price by Type (2021-2026) & (US$/Unit) Table 9. Global Psilocybin Assisted Therapy Sales by Type (2027-2032) & (K Units) Table 10. Global Psilocybin Assisted Therapy Sales Market Share in Volume by Type (2027-2032) Table 11. Global Psilocybin Assisted Therapy Sales by Type (2027-2032) & (US$ Million) Table 12. Global Psilocybin Assisted Therapy Sales Market Share in Value by Type (2027-2032) Table 13. Global Psilocybin Assisted Therapy Price by Type (2027-2032) & (US$/Unit) Table 14. North America Psilocybin Assisted Therapy Sales by Type (2021-2026) & (K Units) Table 15. North America Psilocybin Assisted Therapy Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Psilocybin Assisted Therapy Sales by Type (2021-2026) & (K Units) Table 17. Europe Psilocybin Assisted Therapy Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Psilocybin Assisted Therapy Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Psilocybin Assisted Therapy Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Psilocybin Assisted Therapy Sales by Type (2021-2026) & (K Units) Table 21. Latin America Psilocybin Assisted Therapy Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Psilocybin Assisted Therapy Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Psilocybin Assisted Therapy Sales by Type (2021-2026) & (US$ Million) Table 24. Psilocybin Assisted Therapy Industry Trends Table 25. Psilocybin Assisted Therapy Industry Drivers Table 26. Psilocybin Assisted Therapy Industry Opportunities and Challenges Table 27. Psilocybin Assisted Therapy Industry Restraints Table 28. Global Psilocybin Assisted Therapy Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Psilocybin Assisted Therapy Revenue Market Share by Company (2021-2026) Table 30. Global Psilocybin Assisted Therapy Sales by Company (2021-2026) & (K Units) Table 31. Global Psilocybin Assisted Therapy Sales Share by Company (2021-2026) Table 32. Global Psilocybin Assisted Therapy Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Psilocybin Assisted Therapy Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Psilocybin Assisted Therapy Major Company Production Sites and Headquarters Table 35. Global Psilocybin Assisted Therapy Company, Product Type & Application Table 36. Global Psilocybin Assisted Therapy Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Psilocybin Assisted Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Psilocybin Assisted Therapy Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Psilocybin Assisted Therapy Sales by Region (2021-2026) & (K Units) Table 41. Global Psilocybin Assisted Therapy Sales Market Share in Volume by Region (2021-2026) Table 42. Global Psilocybin Assisted Therapy Sales by Region (2021-2026) & (US$ Million) Table 43. Global Psilocybin Assisted Therapy Sales Market Share in Value by Region (2021-2026) Table 44. Global Psilocybin Assisted Therapy Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Psilocybin Assisted Therapy Sales by Region (2027-2032) & (K Units) Table 46. Global Psilocybin Assisted Therapy Sales Market Share in Volume by Region (2027-2032) Table 47. Global Psilocybin Assisted Therapy Sales by Region (2027-2032) & (US$ Million) Table 48. Global Psilocybin Assisted Therapy Sales Market Share in Value by Region (2027-2032) Table 49. Global Psilocybin Assisted Therapy Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Psilocybin Assisted Therapy Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Psilocybin Assisted Therapy Sales by Application (2021-2026) & (K Units) Table 52. Global Psilocybin Assisted Therapy Sales Market Share in Volume by Application (2021-2026) Table 53. Global Psilocybin Assisted Therapy Sales by Application (2021-2026) & (US$ Million) Table 54. Global Psilocybin Assisted Therapy Sales Market Share in Value by Application (2021-2026) Table 55. Global Psilocybin Assisted Therapy Price by Application (2021-2026) & (US$/Unit) Table 56. Global Psilocybin Assisted Therapy Sales by Application (2027-2032) & (K Units) Table 57. Global Psilocybin Assisted Therapy Sales Market Share in Volume by Application (2027-2032) Table 58. Global Psilocybin Assisted Therapy Sales by Application (2027-2032) & (US$ Million) Table 59. Global Psilocybin Assisted Therapy Sales Market Share in Value by Application (2027-2032) Table 60. Global Psilocybin Assisted Therapy Price by Application (2027-2032) & (US$/Unit) Table 61. North America Psilocybin Assisted Therapy Sales by Application (2021-2026) & (K Units) Table 62. North America Psilocybin Assisted Therapy Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Psilocybin Assisted Therapy Sales by Application (2021-2026) & (K Units) Table 64. Europe Psilocybin Assisted Therapy Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Psilocybin Assisted Therapy Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Psilocybin Assisted Therapy Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Psilocybin Assisted Therapy Sales by Application (2021-2026) & (K Units) Table 68. Latin America Psilocybin Assisted Therapy Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Psilocybin Assisted Therapy Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Psilocybin Assisted Therapy Sales by Application (2021-2026) & (US$ Million) Table 71. ATAI Life Sciences Company Information Table 72. ATAI Life Sciences Business Overview Table 73. ATAI Life Sciences Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. ATAI Life Sciences Psilocybin Assisted Therapy Product Portfolio Table 75. ATAI Life Sciences Recent Development Table 76. Compass Pathways Company Information Table 77. Compass Pathways Business Overview Table 78. Compass Pathways Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Compass Pathways Psilocybin Assisted Therapy Product Portfolio Table 80. Compass Pathways Recent Development Table 81. DemeRx Company Information Table 82. DemeRx Business Overview Table 83. DemeRx Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. DemeRx Psilocybin Assisted Therapy Product Portfolio Table 85. DemeRx Recent Development Table 86. Eleusis Company Information Table 87. Eleusis Business Overview Table 88. Eleusis Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Eleusis Psilocybin Assisted Therapy Product Portfolio Table 90. Eleusis Recent Development Table 91. Field Trip Company Information Table 92. Field Trip Business Overview Table 93. Field Trip Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Field Trip Psilocybin Assisted Therapy Product Portfolio Table 95. Field Trip Recent Development Table 96. Hikma Pharmaceuticals PLC Company Information Table 97. Hikma Pharmaceuticals PLC Business Overview Table 98. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product Portfolio Table 100. Hikma Pharmaceuticals PLC Recent Development Table 101. Jazz Pharmaceuticals Company Information Table 102. Jazz Pharmaceuticals Business Overview Table 103. Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Jazz Pharmaceuticals Psilocybin Assisted Therapy Product Portfolio Table 105. Jazz Pharmaceuticals Recent Development Table 106. MindMed Company Information Table 107. MindMed Business Overview Table 108. MindMed Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. MindMed Psilocybin Assisted Therapy Product Portfolio Table 110. MindMed Recent Development Table 111. Verrian Company Information Table 112. Verrian Business Overview Table 113. Verrian Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Verrian Psilocybin Assisted Therapy Product Portfolio Table 115. Verrian Recent Development Table 116. Pfizer Company Information Table 117. Pfizer Business Overview Table 118. Pfizer Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Pfizer Psilocybin Assisted Therapy Product Portfolio Table 120. Pfizer Recent Development Table 121. North America Psilocybin Assisted Therapy Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. North America Psilocybin Assisted Therapy Sales by Country (2021-2026) & (K Units) Table 123. North America Psilocybin Assisted Therapy Sales Market Share by Country (2021-2026) Table 124. North America Psilocybin Assisted Therapy Sales Forecast by Country (2027-2032) & (K Units) Table 125. North America Psilocybin Assisted Therapy Sales Market Share Forecast by Country (2027-2032) Table 126. North America Psilocybin Assisted Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Psilocybin Assisted Therapy Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Psilocybin Assisted Therapy Market Share by Country (2021-2026) Table 129. North America Psilocybin Assisted Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Psilocybin Assisted Therapy Market Share Forecast by Country (2027-2032) Table 131. Europe Psilocybin Assisted Therapy Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Europe Psilocybin Assisted Therapy Sales by Country (2021-2026) & (K Units) Table 133. Europe Psilocybin Assisted Therapy Sales Market Share by Country (2021-2026) Table 134. Europe Psilocybin Assisted Therapy Sales Forecast by Country (2027-2032) & (K Units) Table 135. Europe Psilocybin Assisted Therapy Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Psilocybin Assisted Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Psilocybin Assisted Therapy Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Psilocybin Assisted Therapy Market Share by Country (2021-2026) Table 139. Europe Psilocybin Assisted Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Psilocybin Assisted Therapy Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Psilocybin Assisted Therapy Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Psilocybin Assisted Therapy Sales by Country (2021-2026) & (K Units) Table 143. Asia-Pacific Psilocybin Assisted Therapy Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Psilocybin Assisted Therapy Sales Forecast by Country (2027-2032) & (K Units) Table 145. Asia-Pacific Psilocybin Assisted Therapy Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Psilocybin Assisted Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Psilocybin Assisted Therapy Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Psilocybin Assisted Therapy Market Share by Country (2021-2026) Table 149. Asia-Pacific Psilocybin Assisted Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Psilocybin Assisted Therapy Market Share Forecast by Country (2027-2032) Table 151. Latin America Psilocybin Assisted Therapy Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Latin America Psilocybin Assisted Therapy Sales by Country (2021-2026) & (K Units) Table 153. Latin America Psilocybin Assisted Therapy Sales Market Share by Country (2021-2026) Table 154. Latin America Psilocybin Assisted Therapy Sales Forecast by Country (2027-2032) & (K Units) Table 155. Latin America Psilocybin Assisted Therapy Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Psilocybin Assisted Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Psilocybin Assisted Therapy Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Psilocybin Assisted Therapy Market Share by Country (2021-2026) Table 159. Latin America Psilocybin Assisted Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Psilocybin Assisted Therapy Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Psilocybin Assisted Therapy Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Psilocybin Assisted Therapy Sales by Country (2021-2026) & (K Units) Table 163. Middle East and Africa Psilocybin Assisted Therapy Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Psilocybin Assisted Therapy Sales Forecast by Country (2027-2032) & (K Units) Table 165. Middle East and Africa Psilocybin Assisted Therapy Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Psilocybin Assisted Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Psilocybin Assisted Therapy Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Psilocybin Assisted Therapy Market Share by Country (2021-2026) Table 169. Middle East and Africa Psilocybin Assisted Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Psilocybin Assisted Therapy Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Psilocybin Assisted Therapy Distributors List Table 174. Psilocybin Assisted Therapy Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Psilocybin Assisted Therapy Image Figure 2. Global Psilocybin Assisted Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Psilocybin Assisted Therapy Market Size (2021-2032) & (US$ Million) Figure 4. Global Psilocybin Assisted Therapy Sales (2021-2032) & (K Units) Figure 5. Natural Image Figure 6. Global Natural Sales YoY Growth (2021-2032) & (K Units) Figure 7. Synthetic Image Figure 8. Global Synthetic Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Psilocybin Assisted Therapy Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Psilocybin Assisted Therapy Market Share by Type 2025 VS 2032 Figure 11. North America Psilocybin Assisted Therapy Sales Market Share in Volume by Type in 2025 Figure 12. North America Psilocybin Assisted Therapy Sales Market Share in Value by Type in 2025 Figure 13. Europe Psilocybin Assisted Therapy Sales Market Share in Volume by Type in 2025 Figure 14. Europe Psilocybin Assisted Therapy Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Psilocybin Assisted Therapy Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Psilocybin Assisted Therapy Sales Market Share in Value by Type in 2025 Figure 17. Latin America Psilocybin Assisted Therapy Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Psilocybin Assisted Therapy Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Psilocybin Assisted Therapy Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Psilocybin Assisted Therapy Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Psilocybin Assisted Therapy Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Psychiatric Disorders Image Figure 24. Global Psychiatric Disorders Sales YoY Growth (2021-2032) & (K Units) Figure 25. Anxiety Disorders Image Figure 26. Global Anxiety Disorders Sales YoY Growth (2021-2032) & (K Units) Figure 27. Cluster Headaches Image Figure 28. Global Cluster Headaches Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Psilocybin Assisted Therapy Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Psilocybin Assisted Therapy Market Share by Application 2025 VS 2032 Figure 31. North America Psilocybin Assisted Therapy Sales Market Share in Volume by Application in 2025 Figure 32. North America Psilocybin Assisted Therapy Sales Market Share in Value by Application in 2025 Figure 33. Europe Psilocybin Assisted Therapy Sales Market Share in Volume by Application in 2025 Figure 34. Europe Psilocybin Assisted Therapy Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Psilocybin Assisted Therapy Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Psilocybin Assisted Therapy Sales Market Share in Value by Application in 2025 Figure 37. Latin America Psilocybin Assisted Therapy Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Psilocybin Assisted Therapy Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Psilocybin Assisted Therapy Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Psilocybin Assisted Therapy Sales Market Share in Value by Application in 2025 Figure 41. North America Psilocybin Assisted Therapy Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Psilocybin Assisted Therapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Psilocybin Assisted Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Psilocybin Assisted Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Psilocybin Assisted Therapy Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Psilocybin Assisted Therapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Psilocybin Assisted Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Psilocybin Assisted Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Psilocybin Assisted Therapy Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Psilocybin Assisted Therapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Psilocybin Assisted Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Psilocybin Assisted Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Psilocybin Assisted Therapy Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Psilocybin Assisted Therapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Psilocybin Assisted Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Psilocybin Assisted Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Psilocybin Assisted Therapy Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Psilocybin Assisted Therapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Psilocybin Assisted Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Psilocybin Assisted Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Psilocybin Assisted Therapy Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Psilocybin Assisted Therapy Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Natural
  • Synthetic
Applications
  • Psychiatric Disorders
  • Anxiety Disorders
  • Cluster Headaches
Companies covered
  • ATAI Life Sciences
  • Compass Pathways
  • DemeRx
  • Eleusis
  • Field Trip
  • Hikma Pharmaceuticals PLC
  • Jazz Pharmaceuticals
  • MindMed
  • Verrian
  • Pfizer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Psilocybin Assisted Therapy Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Psilocybin Assisted Therapy Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Psilocybin Assisted Therapy Market by Type
  6. 1.3.1 Natural
  7. 1.3.2 Synthetic
  8. 1.4 Global Psilocybin Assisted Therapy Market Size by Type
  9. 1.4.1 Global Psilocybin Assisted Therapy Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Psilocybin Assisted Therapy Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Psilocybin Assisted Therapy Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Psilocybin Assisted Therapy Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Psilocybin Assisted Therapy Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Psilocybin Assisted Therapy Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Psilocybin Assisted Therapy Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Psilocybin Assisted Therapy Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Psilocybin Assisted Therapy Industry Trends
  2. 2.2 Psilocybin Assisted Therapy Industry Drivers
  3. 2.3 Psilocybin Assisted Therapy Industry Opportunities and Challenges
  4. 2.4 Psilocybin Assisted Therapy Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Psilocybin Assisted Therapy Revenue (2021-2026)
  2. 3.2 Global Top Players by Psilocybin Assisted Therapy Sales (2021-2026)
  3. 3.3 Global Top Players by Psilocybin Assisted Therapy Price (2021-2026)
  4. 3.4 Global Psilocybin Assisted Therapy Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Psilocybin Assisted Therapy Major Company Production Sites & Headquarters
  6. 3.6 Global Psilocybin Assisted Therapy Company, Product Type & Application
  7. 3.7 Global Psilocybin Assisted Therapy Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Psilocybin Assisted Therapy Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Psilocybin Assisted Therapy Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Psilocybin Assisted Therapy Tier 1, Tier 2, and Tier 3
4 Psilocybin Assisted Therapy Regional Status and Outlook
  1. 4.1 Global Psilocybin Assisted Therapy Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Psilocybin Assisted Therapy Historic Market Size by Region
  3. 4.2.1 Global Psilocybin Assisted Therapy Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Psilocybin Assisted Therapy Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Psilocybin Assisted Therapy Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Psilocybin Assisted Therapy Forecasted Market Size by Region
  7. 4.3.1 Global Psilocybin Assisted Therapy Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Psilocybin Assisted Therapy Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Psilocybin Assisted Therapy Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Psilocybin Assisted Therapy by Application
  1. 5.1 Psilocybin Assisted Therapy Market by Application
  2. 5.1.1 Psychiatric Disorders
  3. 5.1.2 Anxiety Disorders
  4. 5.1.3 Cluster Headaches
  5. 5.2 Global Psilocybin Assisted Therapy Market Size by Application
  6. 5.2.1 Global Psilocybin Assisted Therapy Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Psilocybin Assisted Therapy Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Psilocybin Assisted Therapy Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Psilocybin Assisted Therapy Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Psilocybin Assisted Therapy Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Psilocybin Assisted Therapy Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Psilocybin Assisted Therapy Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Psilocybin Assisted Therapy Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 ATAI Life Sciences
  2. 6.1.1 ATAI Life Sciences Company Information
  3. 6.1.2 ATAI Life Sciences Business Overview
  4. 6.1.3 ATAI Life Sciences Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 ATAI Life Sciences Psilocybin Assisted Therapy Product Portfolio
  6. 6.1.5 ATAI Life Sciences Recent Developments
  7. 6.2 Compass Pathways
  8. 6.2.1 Compass Pathways Company Information
  9. 6.2.2 Compass Pathways Business Overview
  10. 6.2.3 Compass Pathways Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Compass Pathways Psilocybin Assisted Therapy Product Portfolio
  12. 6.2.5 Compass Pathways Recent Developments
  13. 6.3 DemeRx
  14. 6.3.1 DemeRx Company Information
  15. 6.3.2 DemeRx Business Overview
  16. 6.3.3 DemeRx Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 DemeRx Psilocybin Assisted Therapy Product Portfolio
  18. 6.3.5 DemeRx Recent Developments
  19. 6.4 Eleusis
  20. 6.4.1 Eleusis Company Information
  21. 6.4.2 Eleusis Business Overview
  22. 6.4.3 Eleusis Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Eleusis Psilocybin Assisted Therapy Product Portfolio
  24. 6.4.5 Eleusis Recent Developments
  25. 6.5 Field Trip
  26. 6.5.1 Field Trip Company Information
  27. 6.5.2 Field Trip Business Overview
  28. 6.5.3 Field Trip Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Field Trip Psilocybin Assisted Therapy Product Portfolio
  30. 6.5.5 Field Trip Recent Developments
  31. 6.6 Hikma Pharmaceuticals PLC
  32. 6.6.1 Hikma Pharmaceuticals PLC Company Information
  33. 6.6.2 Hikma Pharmaceuticals PLC Business Overview
  34. 6.6.3 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product Portfolio
  36. 6.6.5 Hikma Pharmaceuticals PLC Recent Developments
  37. 6.7 Jazz Pharmaceuticals
  38. 6.7.1 Jazz Pharmaceuticals Company Information
  39. 6.7.2 Jazz Pharmaceuticals Business Overview
  40. 6.7.3 Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Jazz Pharmaceuticals Psilocybin Assisted Therapy Product Portfolio
  42. 6.7.5 Jazz Pharmaceuticals Recent Developments
  43. 6.8 MindMed
  44. 6.8.1 MindMed Company Information
  45. 6.8.2 MindMed Business Overview
  46. 6.8.3 MindMed Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 MindMed Psilocybin Assisted Therapy Product Portfolio
  48. 6.8.5 MindMed Recent Developments
  49. 6.9 Verrian
  50. 6.9.1 Verrian Company Information
  51. 6.9.2 Verrian Business Overview
  52. 6.9.3 Verrian Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Verrian Psilocybin Assisted Therapy Product Portfolio
  54. 6.9.5 Verrian Recent Developments
  55. 6.10 Pfizer
  56. 6.10.1 Pfizer Company Information
  57. 6.10.2 Pfizer Business Overview
  58. 6.10.3 Pfizer Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Pfizer Psilocybin Assisted Therapy Product Portfolio
  60. 6.10.5 Pfizer Recent Developments
7 North America by Country
  1. 7.1 North America Psilocybin Assisted Therapy Sales by Country
  2. 7.1.1 North America Psilocybin Assisted Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Psilocybin Assisted Therapy Sales by Country (2021-2026)
  4. 7.1.3 North America Psilocybin Assisted Therapy Sales Forecast by Country (2027-2032)
  5. 7.2 North America Psilocybin Assisted Therapy Market Size by Country
  6. 7.2.1 North America Psilocybin Assisted Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Psilocybin Assisted Therapy Market Size by Country (2021-2026)
  8. 7.2.3 North America Psilocybin Assisted Therapy Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Psilocybin Assisted Therapy Sales by Country
  2. 8.1.1 Europe Psilocybin Assisted Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Psilocybin Assisted Therapy Sales by Country (2021-2026)
  4. 8.1.3 Europe Psilocybin Assisted Therapy Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Psilocybin Assisted Therapy Market Size by Country
  6. 8.2.1 Europe Psilocybin Assisted Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Psilocybin Assisted Therapy Market Size by Country (2021-2026)
  8. 8.2.3 Europe Psilocybin Assisted Therapy Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Psilocybin Assisted Therapy Sales by Country
  2. 9.1.1 Asia-Pacific Psilocybin Assisted Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Psilocybin Assisted Therapy Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Psilocybin Assisted Therapy Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Psilocybin Assisted Therapy Market Size by Country
  6. 9.2.1 Asia-Pacific Psilocybin Assisted Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Psilocybin Assisted Therapy Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Psilocybin Assisted Therapy Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Psilocybin Assisted Therapy Sales by Country
  2. 10.1.1 South America Psilocybin Assisted Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Psilocybin Assisted Therapy Sales by Country (2021-2026)
  4. 10.1.3 South America Psilocybin Assisted Therapy Sales Forecast by Country (2027-2032)
  5. 10.2 South America Psilocybin Assisted Therapy Market Size by Country
  6. 10.2.1 South America Psilocybin Assisted Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Psilocybin Assisted Therapy Market Size by Country (2021-2026)
  8. 10.2.3 South America Psilocybin Assisted Therapy Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Psilocybin Assisted Therapy Sales by Country
  2. 11.1.1 Middle East and Africa Psilocybin Assisted Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Psilocybin Assisted Therapy Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Psilocybin Assisted Therapy Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Psilocybin Assisted Therapy Market Size by Country
  6. 11.2.1 Middle East and Africa Psilocybin Assisted Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Psilocybin Assisted Therapy Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Psilocybin Assisted Therapy Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Psilocybin Assisted Therapy Value Chain Analysis
  2. 12.1.1 Psilocybin Assisted Therapy Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Psilocybin Assisted Therapy Production Mode & Process
  7. 12.2 Psilocybin Assisted Therapy Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Psilocybin Assisted Therapy Distributors
  10. 12.2.3 Psilocybin Assisted Therapy Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst